# Evaluate the Efficacy and Safety of ON101 Cream for the Treatment of Chronic Diabetic Foot Ulcers

> **NCT01898923** · PHASE3 · COMPLETED · sponsor: **Oneness Biotech Co., Ltd.** · enrollment: 236 (actual)

## Conditions studied

- Diabetic Foot

## Interventions

- **DRUG:** ON101 Cream
- **OTHER:** Aquacel® Hydrofiber® dressing

## Key facts

- **NCT ID:** NCT01898923
- **Lead sponsor:** Oneness Biotech Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-11-23
- **Primary completion:** 2020-05-11
- **Final completion:** 2020-05-11
- **Target enrollment:** 236 (ACTUAL)
- **Last updated:** 2021-04-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01898923

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01898923, "Evaluate the Efficacy and Safety of ON101 Cream for the Treatment of Chronic Diabetic Foot Ulcers". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01898923. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*